-
1
-
-
71049116042
-
Rationale and design of Ferinject assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: A randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia
-
Anker SD, Colet JC, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Luscher TF, Mori C, von Eisenhart RB, Pocock S, Poole-Wilson PA, Ponikowski P. Rationale and design of Ferinject assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia. Eur J Heart Fail 2009;11:1084-1091.
-
(2009)
Eur J Heart Fail
, vol.11
, pp. 1084-1091
-
-
Anker, S.D.1
Colet, J.C.2
Filippatos, G.3
Willenheimer, R.4
Dickstein, K.5
Drexler, H.6
Luscher, T.F.7
Mori, C.8
Von Eisenhart, R.B.9
Pocock, S.10
Poole-Wilson, P.A.11
Ponikowski, P.12
-
3
-
-
84875207643
-
Iron status in patients with chronic heart failure
-
Jankowska EA, Malyszko J, Ardehali H, Koc-Zorawska E, BanasiakW, von Haehling S, Macdougall IC, Weiss G, McMurray JJ, Anker SD, Gheorghiade M, Ponikowski P. Iron status in patients with chronic heart failure. Eur Heart J 2013;34:827-834.
-
(2013)
Eur Heart J
, vol.34
, pp. 827-834
-
-
Jankowska, E.A.1
Malyszko, J.2
Ardehali, H.3
Koc-Zorawska, E.4
Banasiak, W.5
Von Haehling, S.6
Macdougall, I.C.7
Weiss, G.8
McMurray, J.J.9
Anker, S.D.10
Gheorghiade, M.11
Ponikowski, P.12
-
4
-
-
84923680702
-
Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure
-
Jankowska EA, Kasztura M, Sokolski M, Bronisz M, Nawrocka S, Oleskowska-Florek W, Zymlinski R, Biegus J, Siwolowski P, Banasiak W, AnkerSD, Filippatos G, Cleland JG, PonikowskiP. Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure. Eur Heart J 2014; 35:2468-2476.
-
(2014)
Eur Heart J
, vol.35
, pp. 2468-2476
-
-
Jankowska, E.A.1
Kasztura, M.2
Sokolski, M.3
Bronisz, M.4
Nawrocka, S.5
Oleskowska-Florek, W.6
Zymlinski, R.7
Biegus, J.8
Siwolowski, P.9
Banasiak, W.10
Anker, S.D.11
Filippatos, G.12
Cleland, J.G.13
Ponikowski, P.14
-
5
-
-
79960601913
-
Myocardial and systemic iron depletion in heart failure: Implications for anemia accompanying heart failure
-
Maeder MT, Khammy O, dos RC, Kaye DM. Myocardial and systemic iron depletion in heart failure: implications for anemia accompanying heart failure. J Am Coll Cardiol 2011;58:474-480.
-
(2011)
J Am Coll Cardiol
, vol.58
, pp. 474-480
-
-
Maeder, M.T.1
Khammy, O.2
Dos, R.C.3
Kaye, D.M.4
-
6
-
-
84925275800
-
Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency
-
Ponikowski P, van Veldhuisen DJ, Comin-Colet J, Ertl G, Komajda M, Mareev V, McDonagh T, Parkhomenko A, Tavazzi L, Levesque V, Mori C, Roubert B, Filippatos G, Ruschitzka F, Anker SD. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur Heart J 2015;36:657-668.
-
(2015)
Eur Heart J
, vol.36
, pp. 657-668
-
-
Ponikowski, P.1
Van Veldhuisen, D.J.2
Comin-Colet, J.3
Ertl, G.4
Komajda, M.5
Mareev, V.6
McDonagh, T.7
Parkhomenko, A.8
Tavazzi, L.9
Levesque, V.10
Mori, C.11
Roubert, B.12
Filippatos, G.13
Ruschitzka, F.14
Anker, S.D.15
-
7
-
-
72449156527
-
Ferric carboxymaltose in patients with heart failure and iron deficiency
-
Anker SD, Comin CJ, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Luscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart RB, Pocock SJ, Poole-Wilson PA, Ponikowski P. Ferric carboxymaltose in patients with heart failure and iron deficiency.NEngl J Med 2009;361:2436-2448.
-
(2009)
NEngl J Med
, vol.361
, pp. 2436-2448
-
-
Anker, S.D.1
Comin, C.J.2
Filippatos, G.3
Willenheimer, R.4
Dickstein, K.5
Drexler, H.6
Luscher, T.F.7
Bart, B.8
Banasiak, W.9
Niegowska, J.10
Kirwan, B.A.11
Mori, C.12
Von Eisenhart, R.B.13
Pocock, S.J.14
Poole-Wilson, P.A.15
Ponikowski, P.16
-
8
-
-
17444416672
-
Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: A systematic review
-
Olsson LG, Swedberg K, Clark AL, Witte KK, Cleland JG. Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review. Eur Heart J 2005;26: 778-793.
-
(2005)
Eur Heart J
, vol.26
, pp. 778-793
-
-
Olsson, L.G.1
Swedberg, K.2
Clark, A.L.3
Witte, K.K.4
Cleland, J.G.5
-
9
-
-
37849053243
-
Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: A randomized, controlled, observer-blinded trial
-
OkonkoDO,Grzeslo A, WitkowskiT, Mandal AK, Slater RM, Roughton M, Foldes G, Thum T, Majda J, Banasiak W, Missouris CG, Poole-Wilson PA, Anker SD, Ponikowski P. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. J AmColl Cardiol 2008; 51:103-112.
-
(2008)
J AmColl Cardiol
, vol.51
, pp. 103-112
-
-
Okonko, D.O.1
Grzeslo, A.2
Witkowski, T.3
Mandal, A.K.4
Slater, R.M.5
Roughton, M.6
Foldes, G.7
Thum, T.8
Majda, J.9
Banasiak, W.10
Missouris, C.G.11
Poole-Wilson, P.A.12
Anker, S.D.13
Ponikowski, P.14
-
10
-
-
35248870765
-
Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency
-
Toblli JE, Lombrana A, Duarte P, Di Gennaro F. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol 2007;50:1657-1665.
-
(2007)
J Am Coll Cardiol
, vol.50
, pp. 1657-1665
-
-
Toblli, J.E.1
Lombrana, A.2
Duarte, P.3
Di Gennaro, F.4
-
11
-
-
84864493727
-
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
-
McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012;33:1787-1847.
-
(2012)
Eur Heart J
, vol.33
, pp. 1787-1847
-
-
McMurray, J.J.1
Adamopoulos, S.2
Anker, S.D.3
Auricchio, A.4
Bohm, M.5
Dickstein, K.6
Falk, V.7
Filippatos, G.8
Fonseca, C.9
Gomez-Sanchez, M.A.10
Jaarsma, T.11
Kober, L.12
Lip, G.Y.13
Maggioni, A.P.14
Parkhomenko, A.15
Pieske, B.M.16
Popescu, B.A.17
Ronnevik, P.K.18
Rutten, F.H.19
Schwitter, J.20
Seferovic, P.21
Stepinska, J.22
Trindade, P.T.23
Voors, A.A.24
Zannad, F.25
Zeiher, A.26
Bax, J.J.27
Baumgartner, H.28
Ceconi, C.29
Dean, V.30
Deaton, C.31
Fagard, R.32
Funck-Brentano, C.33
Hasdai, D.34
Hoes, A.35
Kirchhof, P.36
Knuuti, J.37
Kolh, P.38
McDonagh, T.39
Moulin, C.40
Popescu, B.A.41
Reiner, Z.42
Sechtem, U.43
Sirnes, P.A.44
Tendera, M.45
Torbicki, A.46
Vahanian, A.47
Windecker, S.48
McDonagh, T.49
Sechtem, U.50
Bonet, L.A.51
Avraamides, P.52
Ben Lamin, H.A.53
Brignole, M.54
Coca, A.55
Cowburn, P.56
Dargie, H.57
Elliott, P.58
Flachskampf, F.A.59
Guida, G.F.60
Hardman, S.61
Iung, B.62
Merkely, B.63
Mueller, C.64
Nanas, J.N.65
Nielsen, O.W.66
Orn, S.67
Parissis, J.T.68
Ponikowski, P.69
more..
-
12
-
-
54349090164
-
Intravenous versus oral iron supplementation for the treatment of anemia in CKD: Systematic review and meta-analysis
-
Rozen-Zvi B, Gafter-Gvili A, Paul M, Leibovici L, Shpilberg O, Gafter U. Intravenous versus oral iron supplementation for the treatment of anemia in CKD: systematic review and meta-analysis. Am J Kidney Dis 2008;52:897-906.
-
(2008)
Am J Kidney Dis
, vol.52
, pp. 897-906
-
-
Rozen-Zvi, B.1
Gafter-Gvili, A.2
Paul, M.3
Leibovici, L.4
Shpilberg, O.5
Gafter, U.6
-
13
-
-
84871970897
-
The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: A subanalysis of the FAIR-HF study
-
Comin-Colet J, Lainscak M, Dickstein K, Filippatos GS, Johnson P, Luscher TF, Mori C, Willenheimer R, Ponikowski P, Anker SD. The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study. Eur Heart J 2013;34:30-38.
-
(2013)
Eur Heart J
, vol.34
, pp. 30-38
-
-
Comin-Colet, J.1
Lainscak, M.2
Dickstein, K.3
Filippatos, G.S.4
Johnson, P.5
Luscher, T.F.6
Mori, C.7
Willenheimer, R.8
Ponikowski, P.9
Anker, S.D.10
-
15
-
-
84886283852
-
IRON-HF study: A randomized trial to assess the effects of iron in heart failure patients with anemia
-
Beck-da-Silva L, Piardi D, Soder S, Rohde LE, Pereira-Barretto AC, de Albuquerque D, Bocchi E, Vilas-Boas F, Moura LZ, Montera MW, Rassi S, Clausell N. IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia. Int J Cardiol 2013;168:3439-3442.
-
(2013)
Int J Cardiol
, vol.168
, pp. 3439-3442
-
-
Beck-Da-Silva, L.1
Piardi, D.2
Soder, S.3
Rohde, L.E.4
Pereira-Barretto, A.C.5
De Albuquerque, D.6
Bocchi, E.7
Vilas-Boas, F.8
Moura, L.Z.9
Montera, M.W.10
Rassi, S.11
Clausell, N.12
|